These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 5637287)
1. Spleen shielding in survivors of the atomic bomb. Gregory PB; Milton RC; Johnson ML; Taura T Radiat Res; 1968 Feb; 33(2):204-15. PubMed ID: 5637287 [No Abstract] [Full Text] [Related]
2. A regression analysis on the mortality of the Hiroshima atomic bomb survivors. Watanabe M Hiroshima J Med Sci; 1970 Sep; 19(2):119-23. PubMed ID: 5512079 [No Abstract] [Full Text] [Related]
3. Capillary microscopic observation on the superficial minute vessels of atomic bomb survivors, Hiroshima, 1972-73. Tsuya A; Wakano Y; Otake M; Dock DS Radiat Res; 1977 Nov; 72(2):353-63. PubMed ID: 918264 [No Abstract] [Full Text] [Related]
4. An analysis of various aspects of atomic bomb dose estimation at RERF using data on acute radiation symptoms. Gilbert ES; Ohara JL Radiat Res; 1984 Oct; 100(1):124-38. PubMed ID: 6494426 [TBL] [Abstract][Full Text] [Related]
5. Bomb survivors and radiation protection. Lodico A Radiol Technol; 2009; 80(6):573-8. PubMed ID: 19584366 [No Abstract] [Full Text] [Related]
6. Age-time patterns for cancer and noncancer excess risks in the atomic bomb survivors. Preston DL; Pierce DA; Shimizu Y Radiat Res; 2000 Dec; 154(6):733-4;discussion 734-5. PubMed ID: 11187021 [No Abstract] [Full Text] [Related]
7. Cancer and non-cancer effects in Japanese atomic bomb survivors. Little MP J Radiol Prot; 2009 Jun; 29(2A):A43-59. PubMed ID: 19454804 [TBL] [Abstract][Full Text] [Related]
9. Hepatitis associated antigen and antibody in A-bomb survivors and nonexposed subjects in Hiroshima and Nagasaki. Belsky JL; Okochi K; Ishimaru T; Hamilton HB Radiat Res; 1972 Dec; 52(3):528-35. PubMed ID: 4539561 [No Abstract] [Full Text] [Related]
10. Studies of the mortality of A-bomb survivors. Report 7. Mortality, 1950-1978: Part II. Mortality from causes other than cancer and mortality in early entrants. Kato H; Brown CC; Hoel DG; Schull WJ Radiat Res; 1982 Aug; 91(2):243-64. PubMed ID: 7100400 [No Abstract] [Full Text] [Related]
12. Autoantibodies and immunoglobulins among atomic bomb survivors. Fujiwara S; Carter RL; Akiyama M; Akahoshi M; Kodama K; Shimaoka K; Yamakido M Radiat Res; 1994 Jan; 137(1):89-95. PubMed ID: 8265792 [TBL] [Abstract][Full Text] [Related]
13. Long-term effects of radiation dose on inflammatory markers in atomic bomb survivors. Hayashi T; Morishita Y; Kubo Y; Kusunoki Y; Hayashi I; Kasagi F; Hakoda M; Kyoizumi S; Nakachi K Am J Med; 2005 Jan; 118(1):83-6. PubMed ID: 15639214 [No Abstract] [Full Text] [Related]
14. Liver function in survivors of the atomic bomb. Gregory PB; Amamoto K; Archer PG; Rickert RR; Omori Y; Bizzozero OJ; Hamilton HB; Johnson KG Radiat Res; 1975 Sep; 63(3):578-83. PubMed ID: 1162040 [No Abstract] [Full Text] [Related]
15. Spleen index in atomic bomb survivors. Doughty WE; Anderson RE; Yamamoto T; Webber LS Arch Pathol; 1973 Dec; 96(6):395-8. PubMed ID: 4784869 [No Abstract] [Full Text] [Related]
16. Comments on the article "Studies of the mortality of atomic bomb survivors. Report 12, part I. Cancer: 1950-1990" by D. A. Pierce, Y. Shimizu. D. L. Preston, M. Vaeth and K. Mabuchi (Radiat. Res. 146, 1-27, 1996). Little MP Radiat Res; 1997 Oct; 148(4):399-401. PubMed ID: 9339957 [No Abstract] [Full Text] [Related]
17. Capillary microscopic observation on the superficial minute vessels of atomic bomb survivors, 1956-1957. Tsuya A; Wakano Y; Otake M Radiat Res; 1971 Apr; 46(1):199-216. PubMed ID: 5574239 [No Abstract] [Full Text] [Related]
20. The relationship of gamma and neutron radiation to posterior lenticular opacities among atomic bomb survivors in Hiroshima and Nagasaki. Otake M; Schull WJ Radiat Res; 1982 Dec; 92(3):574-95. PubMed ID: 7178422 [No Abstract] [Full Text] [Related] [Next] [New Search]